U.S. markets close in 23 minutes
  • S&P 500

    3,689.33
    +103.71 (+2.89%)
     
  • Dow 30

    29,566.55
    +841.04 (+2.93%)
     
  • Nasdaq

    10,855.65
    +280.03 (+2.65%)
     
  • Russell 2000

    1,714.85
    +50.14 (+3.01%)
     
  • Crude Oil

    83.44
    +3.95 (+4.97%)
     
  • Gold

    1,707.40
    +35.40 (+2.12%)
     
  • Silver

    20.75
    +1.71 (+8.96%)
     
  • EUR/USD

    0.9821
    +0.0020 (+0.21%)
     
  • 10-Yr Bond

    3.6510
    -0.1530 (-4.02%)
     
  • GBP/USD

    1.1318
    +0.0152 (+1.36%)
     
  • USD/JPY

    144.7210
    -0.0080 (-0.01%)
     
  • BTC-USD

    19,528.71
    +279.82 (+1.45%)
     
  • CMC Crypto 200

    443.56
    +8.21 (+1.89%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

Unlike Other Former SPACs, Rocket Lab Is Already Science, Not Fiction

·3 min read
Unlike Other Former SPACs, Rocket Lab Is Already Science, Not Fiction

Investors have lumped Rocket Lab together with other moonshots that hit the market in 2021, but the small-satellite launcher has already proven its business model and will benefit from a post-Ukraine increase in military spending.